Dr. Rinat Bernstein-Molho graduated from Israeli Institute of Technology Medical School in Haifa at 2004. She completed her residency in Medical Oncology and then an additional residency in Medical Genetics at Tel Aviv Medical Center. She was in charge of oncogenetic clinic at Tel Aviv Medical Center.
She joined Breast Cancer institute in the Sheba Medical Center at Tel Hashomer in 2017, where she works as a medical oncologist and clinical cancer geneticist. Her area of clinical and research interest is hereditary cancers.
- Senior specialist at Breast Cancer Unit, Oncology Institute
Conditions and treatment
Education and Training
- Dr. Rinat Bernstein Molho graduated with honors from the Faculty of Medicine at Technion University, Haifa.
- She then specialized in Oncology at the Department of Oncology, Tel Aviv Medical Center.
- Also she specialized in Genetics at the Institute of Genetics, Tel Aviv Medical Center.
The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations. Barnes-Kedar I, Bernstein-Molho R, Ginzach N, Hartmajer S, Shapira T, Magal N, Kalis ML, Peretz T, Shohat M, Basel-Salmon L, Friedman E, Bazak L, Goldberg Y.
Evaluation of tolerability and efficacy of incorporating carboplatin in neoadjuvant anthracycline and taxane based therapy in a BRCA1 enriched triple-negative breast cancer cohort. Sella T, Gal Yam EN, Levanon K, Rotenberg TS, Gadot M, Kuchuk I, Molho RB, Itai A, Modiano TM, Gold R, Kaufman B, Shimon SP.